At close: December 24 at 4:00:00 PM EST
After hours: December 24 at 4:30:43 PM EST
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Corey N. Fishman | President, CEO & Director | 1.3M | -- | 1965 |
| Ms. Judith M. Matthews | Chief Financial Officer | 747.77k | -- | 1970 |
| Dr. Michael W. Dunne M.D. | Strategic Advisor & Director | 115k | -- | 1960 |
| Mr. Tom Loughman Ph.D. | Senior Vice President of Technical Operations | -- | -- | -- |
| Ms. Louise Barrett | Senior Vice President of Legal Affairs & Secretary | -- | -- | -- |
| Dr. Steven I. Aronin M.D. | Senior VP & Head of Clinical Development | -- | -- | -- |
Iterum Therapeutics plc
Fitzwilliam Court
1st Floor Leeson Close
Dublin, D02 YW24
Ireland
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 14
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
Corporate Governance
Iterum Therapeutics plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 24, 2025 at 12:30 PM UTC - April 8, 2025 at 12:30 PM UTC
Iterum Therapeutics plc Earnings Date
Recent Events
Related Tickers
MIST Milestone Pharmaceuticals Inc.
1.8500
0.00%
PALI Palisade Bio, Inc.
1.7100
-2.29%
CARA Cara Therapeutics, Inc.
0.4636
+1.36%
VRAX Virax Biolabs Group Limited
1.7200
-10.42%
EYEN Eyenovia, Inc.
0.0856
+1.30%
ENSC Ensysce Biosciences, Inc.
9.98
+20.82%
OTLK Outlook Therapeutics, Inc.
1.4700
+3.52%
DRMA Dermata Therapeutics, Inc.
1.3400
+8.94%
ADIL Adial Pharmaceuticals, Inc.
1.0500
+1.94%
SYRS Syros Pharmaceuticals, Inc.
0.2029
-0.49%